DOI: http://dx.doi.org/10.18203/2349-3933.ijam20204074

Analysis of drug resistant cases of pulmonary tuberculosis with special reference to causes

Surendra Kumar, Ganesh Patel, Mukesh Kalera, J. K. Choudhary

Abstract


Background: Despite advancement of newer diagnostic tools and medicine Drug resistant tuberculosis (DRTB) is a challenge which cannot be eliminated without public participation. This study was designed to know etiology of the drug resistant pulmonary tuberculosis cases.

Methods: Prospective observational study was undertaken among adult patients in a tertiary care hospital 50 patients were studied and analyzed, all patients who were drug resistant either mono or poly from Revised national tuberculosis control programme (RNTCP) accredited lab were included in the study. Factors leading to resistance were analyzed.

Results: Of the 50 patients included in this study majority were male 72%, 68% rural population, 34% were daily wedge worker and 14% were farmer. 78% patients of study group had income <50,000 per annum or dependent to others, associated comorbidities were alcoholic cirrhosis (18%), diabetes mellitus (16%), pyothorax (16%) and hepatic disorder (12%). Cause of default included side effect 26%, longer duration 34%, feeling well (26%), social stigma (12%), financial problem in (20%), poor supply of anti-tubercular drugs (8%) and negative attitude of drug provider (6%).

Conclusions: Poor education lead to less awareness about tuberculosis its diagnosis and adequate treatment, financial crisis leads to early termination in non-Dots. Drug default was most important factor for drug resistance. RNTCP provides free medication by DOTS leading to less default and early diagnosis of DRTB.


Keywords


Drug resistant pulmonary tuberculosis, Default, DOTS, RNTCP

Full Text:

PDF

References


Gutierrez MC, Brisse S, Brosch R, Fabre M, Omais B, Marmiesse M et al. Ancient origin and gene mosaicism of the progenitor of Mycobacterium tuberculosis. PLoS Pathog. 2005;1(1):e5.

Thakker H, Shah JR. Multi drug resistance pulmonary tuberculosis. Indian J Tuberc. 1998;45:131-9.

Nigam P, Dubey AL, Dayal SG, Goyal BM, Saxena HN, Samuel KC. The association of leprosy and pulmonary tuberculosis. Lepr India 1979;51:65-73.

Kotokey RK. An Evaluation of Factors for Default in Smear Positive Pulmonary Tuberculosis Patients Treated with DOTS under RNTCP. Assam J Int Med. 2013;3:e1.

Meriki HD, Kukwah. Drug Resistance Profiles of Mycobacterium tuberculosis Complex and Factors Associated with Drug Resistance in the Northwest and Southwest Regions of Cameroon. Journal pone. 2013;8(10):e77410.

Cherkaoui I, Sabouni R, Ghali I, Kizub D, Billioux AC, Bennani K, et al. Treatment Default amongst Patients with Tuberculosis in Urban Morocco: Predicting and Explaining Default and Post-Default Sputum Smear and Drug Susceptibility Results. PLoS ONE. 2014;9(4): e93574.

Djibuti M, Mirvelashvili E, Makharashvili N, Magee MJ. Household income and poor treatment outcome among patients with tuberculosis in Georgia. BMC Public Health. 2014;14:88.

Gaude GS, Hattiholli J, Kumar P. Risk factors and drug-resistance patterns among pulmonary tuberculosis patients in northern Karnataka region. India Niger Med J. 2014;55(4):327-32.

Tsuchiya T, Kondo A, Sakatani M. Epidemiologic study of the actual investigation of chronic excretors of Mycobacterium tuberculosis bacilli. Kekkaku. 1996;71(1):31-6.

Wahab F. Risk Factors for Multi-Drug Resistant Tuberculosis in Patients at Tertiary Care Hospital. Peshawar J Coll Physicians Surgeons Pakistan. 2009;19(3):162-4.

Yagi T, Yamagishi F, SASAKI Y, Hamaoka T, Kuroda F, Higurashi H. Clinical analysis of multidrug-resistant tuberculosis. Kekkaku (Tuberculosis). 2001;76(12):717-21.